Global Health Full-time

Manager, AI - Diagnostics

Clinton Health Access Initiative (CHAI)

Posted

Aug 26, 2026

Location

Remote (US)

Type

Full-time

Mission

What you will drive

Lead research and analytics for AI diagnostic tools in low- and middle-income countries, evaluating technical readiness and impact potential.
- Scan and assess AI diagnostic landscape; evaluate training data quality, model architectures, and regulatory pathways for priority tools.
- Identify high-burden conditions lacking viable AI diagnostics using disease-burden data to inform investment priorities.
- Develop market intelligence on AI diagnostics covering evidence, performance, cost, and regulatory status for internal and external partners.
- Requires 4–8 years quantitative experience (data science, statistics, epidemiology, or related field) and solid machine learning fundamentals.
- Requires Python or R proficiency, comfort with modern AI tools, and ability to work independently in ambiguous, fast-moving environments.

Profile

What makes you a great fit

Lead research and analytics for AI diagnostic tools in low- and middle-income countries, evaluating technical readiness and impact potential.
- Scan and assess AI diagnostic landscape; evaluate training data quality, model architectures, and regulatory pathways for priority tools.
- Identify high-burden conditions lacking viable AI diagnostics using disease-burden data to inform investment priorities.
- Develop market intelligence on AI diagnostics covering evidence, performance, cost, and regulatory status for internal and external partners.
- Requires 4–8 years quantitative experience (data science, statistics, epidemiology, or related field) and solid machine learning fundamentals.
- Requires Python or R proficiency, comfort with modern AI tools, and ability to work independently in ambiguous, fast-moving environments.

About

Inside Clinton Health Access Initiative (CHAI)

Visit site →

Clinton Health Access Initiative is a nonprofit that works to strengthen health systems and improve access to medicines in low- and middle-income countries.